预测治疗反应和基于免疫检查点抑制剂的综合疗法的预后在晚期肝细胞癌使用纵向CT-based radiomics模型:一个多中心研究研究

Jun Xu1,2,3,4, Junjun Li5, Tengfei Wang6,7,8

  • 1Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, People's Republic of China.

BMC cancer
|April 4, 2025
PubMed
概括

一个新的放射学模型准确地预测了接受免疫检查点抑制剂 (ICI) 组合治疗的晚期肝细胞癌 (HCC) 患者的治疗反应和预后. 这一工具有助于个性化治疗HCC的决策.